Тамар Перец

Научные публикации

• Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report
• A universal cell-free DNA approach for response prediction to preoperative chemoradiation in rectal cancer
• Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response
• PTX Treatment of Colon Cancer: Mode of Action Based on Tumor Marker and Cytokine Kinetics
• Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma
• Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics
• Breast Cancer with Low Recurrence Score on Oncotype DX^©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation
• Potential Refinement of Recurrence Score by pSTAT3 Status
• Predictors of quality of life among adults with self-reported cancer related cognitive impairment
• Genetic anticipation of breast cancer among BRCA1/BRCA2 mutation carriers: A retrospective study
• Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews
• Liquid biopsy reveals collateral tissue damage in cancer
• Thyroid Hormones and Morphological Features of Primary Breast Cancer
• Effect of pentoxifylline on colon cancer patients treated with chemotherapy (Part I)
• "High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis"
• A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer
• Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions
• Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
• Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast Cancer
• Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
• ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
• Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review
• Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer
• Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer
• Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants
• Correction: Exclusive destruction of mitotic spindles in human cancer cells
• Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients
• SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint
• Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma-A Retrospective Study
• Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
• Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma
• Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
• Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization
• Heparanase Accelerates Obesity-Associated Breast Cancer Progression
• The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients
• Variable Features of Juvenile Polyposis Syndrome With Gastric Involvement Among Patients With a Large Genomic Deletion of BMPR1A
• Life and death of circulating cell-free DNA
• Lacosamide at therapeutic concentrations induces histone hyperacetylation in vitro
• Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T Cells
• Potent Activation of Human T Cells by mRNA Encoding Constitutively Active CD40
• Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer
• Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
• Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma -potential predictive markers for adjuvant treatment: a pilot study
• The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations
• Defects in homologous recombination repair genes are associated with good prognosis and clinical sensitivity to DNA-damaging agents in pancreatic cancer: A case report
• SYK expression level distinguishes control from BRCA1-mutated lymphocytes
• Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy
• Breast cancer among older women: The influence of age and cancer stage on survival
• Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
• Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers